Immune Checkpoint Inhibitors Clinical Trials

49 clinical trials for Immune Checkpoint Inhibitors across international registries, including 16 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Adjuvant Immune Checkpoint Inhibitor Versus Observation After Neoadjuvant Immunochemotherapy and Surgery in High-Risk NSCLC — RECRUITING · PHASE2
• Perioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bladder Cancer (NIAGARA-2) — RECRUITING · PHASE3
• DETERMINANTS OF IMMUNOTHERAPY EFFICACY IN ENDOMETRIAL CANCER — RECRUITING · NA
• Development and Application of a Thrombosis Risk Prediction Model in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors — RECRUITING
• Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric Junction — RECRUITING · PHASE2
• A Qualitative Assessment of the Severity and Impact of Rheumatic Immune-Related Adverse Events Following Immune Checkpoint Inhibitor Immunotherapy — RECRUITING
• Observational Cohort Study of Chronic Viral Infection in the Central Nervous System — RECRUITING
• ctDNA-MRD Guided Escalation of Ivonescimab and Docetaxel in Advanced NSCLC With Long-Term Responses to First-line Immunotherapy (CR1STAL-Adaptive) — RECRUITING · PHASE2
• The Impact of Emotional Stress on Immunotherapy Outcomes in Liver Cancer Patients: A Multi-Cohort Study — RECRUITING
• Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and Melanoma — RECRUITING · PHASE1
• Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-small Cell Lung Cancer — RECRUITING · PHASE2
• Identification of Predictive Biomarkers for Immune-Related Adverse Events (irAEs) in Patients Undergoing Immune CheckPoint Inhibitors (ICPI) Treatment — RECRUITING · NA
• The Associations of Sleep Disturbance With Therapy Efficacy and Prognosis of Lung Cancer — RECRUITING
• The Associations of Psychological Stress With Therapy Efficacy and Prognosis of Lung Cancer (STRESS-LUNG) — RECRUITING
• Fruquintinib After ICIs Treatment in Unresectable Hepatocellular Carcinoma — RECRUITING · PHASE2
• Neoantigen Vaccines in Esophageal Squamous Cell Carcinoma — RECRUITING · PHASE2
• COVICI-SURV: COVID-19 Vaccination Around ICI Start and Survival — ACTIVE_NOT_RECRUITING
• Phase II Trial of SFRT Plus Chemo-immunotherapy for LA-NSCLC With Suboptimal Neoadjuvant Response — NOT_YET_RECRUITING · PHASE2
• Real-world Study on the Efficacy, Safety, and Prognostic Factors of Immune Checkpoint Inhibitors Combined With Radiotherapy in Patients With Malignant Tumors: A Prospective Non-interventional Clinical Study — NOT_YET_RECRUITING
• Analysis of Efficacy and Outcomes of Immunotherapy for Malignant Tumors: A Prospective Non-interventional Clinical Study — NOT_YET_RECRUITING
• Organ-Specific Differences in Immunotherapy Response Among Metastatic Cancer Patients — COMPLETED
• Exploratory Study on the Efficacy and Safety of Nebulized hUC-MSC-Derived Exosomes for Non-Acute CIP — NOT_YET_RECRUITING · PHASE1
• Efficacy and Safety of Immune Checkpoint Inhibitors for Refractory Opportunistic Infections in AIDS — NOT_YET_RECRUITING · PHASE1
• Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population — ACTIVE_NOT_RECRUITING
• Neoadjuvant Therapy for Early Triple-Negative Breast Cancer: A Response-Guided Approach Using Iparomlimab and Tuvonralimab Injection in Combination With Chemotherapy — NOT_YET_RECRUITING · PHASE2
• Impact of Pretreatment Emotional Distress on Survival and the Predictive Role of Peripheral Biomarkers in Immunotherapy Response Among Gastroesophageal and Lung Cancer Patients — COMPLETED
• Neoadjuvant Tislelizumab With Chemotherapy for the Treatment of MSS Colon Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Disitamab Vedotin Plus Lenvatinib and PD-1 Inhibitors for Treating HER2-positive Advanced Biliary Tract Cancer — NOT_YET_RECRUITING · PHASE2
• Neoadjuvant CAPOX Plus Tislelizumab vs CAPOX in MSS High-Risk Locally Advanced Colon Cancer — NOT_YET_RECRUITING · PHASE3
• Impact of Therapeutic Patient Education on the Toxicity of Immune Checkpoint Inhibitors in Oncology — COMPLETED · NA
• Fecal Microbiota Transplantation in Patients With Malignancies Not Responding to Cancer Immunotherapy — COMPLETED · NA
• Immune Checkpoint Inhibitors (ICIs) Retreatment in Second-line Treatment of Advanced Gastric Cancer: a Retrospective, Real-world Study — NOT_YET_RECRUITING
• HAIC in Combination with Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors for Advanced HCC — ACTIVE_NOT_RECRUITING
• Relationship Between Immunity and Metabolism in Patients Receiving Immune Checkpoint Inhibitors for Advanced Cancer. ( RIMEC ) — OTHER · NA
• A Clinical Study on the Analysis of Risk Factors for the Occurrence of PD-1/PD-L1 Inhibitor-associated Liver Injury in Lung Cancer Patients — OTHER
• Imaging Biomarkers for Immune Checkpoint Inhibitor Treatment in Patients With Non-small Cell Lung Cancer — OTHER
• Fertility and Pregnancy After Avelumab Treatment — OTHER · NA
• Upfront Immune Checkpoint Inhibitors With Deferred Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma — NOT_YET_RECRUITING · PHASE2
• Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer — OTHER · NA
• Efficacy and Safety of SBRT Combined With Cardonilizumab and Lenvastinib in the Treatment of Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus — OTHER · PHASE1
• Cadonilimab in the Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma — OTHER · PHASE1
• irAE Prediction of Anti-PD-1/L1 in Lung Cancer — OTHER
• The Efficacy of Chemotherapy Combined With Immunocheckpoint Inhibitors in Advanced Biliary Malignancies — OTHER · PHASE2
• Assessment of Myocardial Injury in Patients Treated With Immune Checkpoint Inhibitors — OTHER
• Tislelizumab and Radiotherapy for Recurrent Cervical Cancer — OTHER · PHASE2
• PD-1 Antibody and Radiotherapy for Recurrent Cervical Cancer — OTHER
• Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy: Multi-Center Trial — OTHER · PHASE2
• A Perspective, Self-control Study on the Progression of Carotid Plaques in Anti-PD-1 mAb Treated Tumor Patients by Artery Ultrasound Follow-up — OTHER
• A Study of Camrelizumab Combined Apatinib in Hepatocellular Carcinoma Previously Treated With Immune Checkpoint Inhibitors (ICIs). — OTHER · PHASE2

Refine this search